Medical Equipment

Projected Growth of the Global Structural Heart Devices Market to Reach $16.1 Billion by 2029

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the structural heart devices market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Structural Heart Devices Market By The End Of 2029?

The structural heart devices market has experienced robust expansion over the last few years. Forecasts indicate it will expand from $10.41 billion in 2024 to $11.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.3%. Historically, this growth is primarily due to several factors, including a move towards less invasive surgical methods, an increasing need for minimally invasive structural heart devices, continuous training and educational initiatives for medical practitioners, increasing healthcare spending, and a growing patient inclination for non-surgical or minimally invasive treatment choices.

The market for structural heart devices is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $16.1 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.1%. The expansion during the projected period stems from factors such as a rising elderly population, heightened awareness regarding heart health, the introduction of comprehensive screening initiatives, supportive reimbursement policies for structural heart interventions, and prompt regulatory clearances for novel structural heart devices. Key trends anticipated for this forecast timeframe encompass the expanding use of transcatheter valve replacement, continuous innovation in device development utilizing advanced materials, a heightened focus on individualized treatment strategies, the rising prevalence of hybrid procedures, and the incorporation of remote monitoring and telehealth technologies.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15677&type=smp

Which Business Drivers Are Underpinning The Growth Of The Structural Heart Devices Market?

The increasing occurrence of cardiovascular diseases is anticipated to accelerate the expansion of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) are a category of conditions affecting the heart and blood vessels, encompassing ailments such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, attributed to factors like sedentary lifestyles, inadequate dietary habits, escalating obesity rates, smoking, and an aging population. Structural heart devices serve to treat cardiovascular diseases by repairing or replacing damaged heart valves, correcting structural defects, and improving heart function and overall patient outcomes. For instance, in September 2024, data published by the British Heart Foundation, a UK-based cardiovascular research charity, revealed that in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Consequently, the escalating prevalence of cardiovascular diseases is a key driver for the growth of the structural heart device market.

What Are The Principal Segment Types In The Structural Heart Devices Market?

The structural heart devicesmarket covered in this report is segmented –

1) By Type: Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems

2) By Procedure: Replacement Procedures, Repair Procedures

3) By Indication: Atrial Septal Defect, Patent Foramen Ovale, Ventricular Septal Defect, Aortic Valve Stenosis, Other Indications

4) By Age Group: Pediatric, Adults

Subsegments:

1) By Heart Valve Devices: Transcatheter Heart Valves, Surgical Heart Valves, Annuloplasty Rings

2) By Annuloplasty Rings: Mitral Annuloplasty Rings, Aortic Annuloplasty Rings

3) By Occluders: Atrial Septal Defect (Asd) Occluders, Patent Foramen Ovale (Pfo) Occluders

4) By Delivery Systems: Balloon Delivery Systems, Catheter-Based Delivery Systems

Which Long-Term Trends Will Play A Crucial Role In The Structural Heart Devices Market?

Major companies engaged in the structural heart devices market are pursuing the development of minimally invasive treatment procedures and related devices. This effort is aimed at enhancing patient outcomes, shortening recovery times, and broadening the scope of treatment options for structural heart conditions. A prime example of such technology is the self-expanding transcatheter aortic valve implantation (TAVI) system, which is designed to precisely position and secure a replacement valve within the native aortic valve anatomy without the need for balloon inflation. Illustratively, in December 2022, Abbott Laboratories, a US-based company known for manufacturing medical devices and healthcare products, launched its advanced-generation transcatheter aortic valve implantation (TAVI) system, Navitor, in India. This system is tailored for individuals diagnosed with severe aortic stenosis who face high or extreme surgical risk, and it incorporates enhancements such as a unique design to prevent valve leakage. Navitor significantly strengthens Abbott’s structural heart transcatheter portfolio, presenting physicians and patients with less invasive treatment alternatives for various heart diseases. Notably, it stands out as the only self-expanding TAVI system featuring intra-annular leaflets and large frame cells, a design that facilitates improved access to coronary arteries for potential future interventions in coronary artery disease (CAD). Additionally, this innovative design leads to improved hemodynamics, optimizing blood flow.

Which Companies Are Contributing Significantly To The Structural Heart Devices Market Growth?

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomédica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Which Region Offers The Most Opportunity For Structural Heart Devices Market Expansion?

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15677&type=smp

Browse Through More Reports Similar to the Global Structural Heart Devices Market 2025, By The Business Research Company

Structural Heart Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/structural-heart-global-market-report

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795